These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 12720205

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Outcome after cessation of therapy in childhood leukemia. A population-based Nordic study of 986 patients.
    Nygaard R, Moe PJ.
    Acta Paediatr Scand Suppl; 1989; 354():1-24. PubMed ID: 2596294
    [No Abstract] [Full Text] [Related]

  • 23. Use of simplified strategies to evaluate early treatment response in childhood acute lymphoblastic leukemia.
    Scrideli CA, de Paula Queiróz R, Bernardes JE, Defavery R, Valera ET, Tone LG.
    Leuk Res; 2006 Aug; 30(8):1049-52. PubMed ID: 16406015
    [Abstract] [Full Text] [Related]

  • 24. [Childhood acute lymphoblastic leukemia in Norway 1992-2000].
    Kolmannskog S, Flaegstad T, Helgestad J, Hellebostad M, Zeller B, Glomstein A.
    Tidsskr Nor Laegeforen; 2007 May 31; 127(11):1493-5. PubMed ID: 17551551
    [Abstract] [Full Text] [Related]

  • 25. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
    Takanashi M, Morimoto A, Yagi T, Kuriyama K, Kano G, Imamura T, Hibi S, Todo S, Imashuku S.
    Haematologica; 2003 Nov 31; 88(11):1238-44. PubMed ID: 14607752
    [Abstract] [Full Text] [Related]

  • 26. Hodgkin lymphoma as second malignancy during continuing chemotherapy for childhood acute lymphoblastic leukemia.
    Alebouyeh M, Moussavi F, Haddad-Deylami H, Vossough P.
    Klin Padiatr; 2008 Nov 31; 220(6):388-90. PubMed ID: 18949677
    [Abstract] [Full Text] [Related]

  • 27. Treatment of childhood acute lymphoblastic leukemia at a regional non-academic center in Belarus.
    Chunikhovskiy SP, Zelterman D, van Hoff J.
    Med Pediatr Oncol; 2002 Sep 31; 39(3):202-6. PubMed ID: 12210452
    [Abstract] [Full Text] [Related]

  • 28. Is the in vitro drug resistance profile the strongest prognostic factor in childhood acute lymphoblastic leukemia?
    Styczynski J, Wysocki M.
    J Clin Oncol; 2004 Mar 01; 22(5):963-4. PubMed ID: 14990658
    [No Abstract] [Full Text] [Related]

  • 29. Atypical pyoderma gangrenosum as a manifestation of childhood acute lymphoblastic leukemia.
    Bakhshi S, Sethuraman G, Singh MK, Arya LS.
    Pediatr Dermatol; 2005 Mar 01; 22(6):543-5. PubMed ID: 16354258
    [Abstract] [Full Text] [Related]

  • 30. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. II. Clinical picture and prognosis in specific immunological subgroups].
    Kołecki P, Radwańska U.
    Pediatr Pol; 1988 Nov 01; 63(11):698-702. PubMed ID: 3253656
    [No Abstract] [Full Text] [Related]

  • 31. [Childhood leukemia from the perspective of 15 years of its intensive treatment].
    Radwańska U.
    Pediatr Pol; 1988 Nov 01; 63(11):689-92. PubMed ID: 3253654
    [No Abstract] [Full Text] [Related]

  • 32. Higher urinary excretion of inorganic phosphate during early induction chemotherapy predicts a good prognosis in childhood acute leukemia.
    Ichikawa M, Kobayashi R, Nakajima M, Inamoto J, Suzuki D, Cho Y, Kaneda M, Yoshida M, Ariga T.
    J Pediatr Hematol Oncol; 2011 May 01; 33(4):e143-8. PubMed ID: 21423043
    [Abstract] [Full Text] [Related]

  • 33. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ, Shi SW, Tang YM, Song H, Yang SL, Wei J, Xu WQ, Pan BH, Chen YH, Zhao FY, Shen HQ, Qian BQ, Zhang LY, Ning BT.
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb 01; 9(1):28-33. PubMed ID: 17306073
    [Abstract] [Full Text] [Related]

  • 34. Acute lymphoblastic leukemia: current treatment concepts.
    Arya LS.
    Indian Pediatr; 2000 Apr 01; 37(4):397-406. PubMed ID: 10781233
    [No Abstract] [Full Text] [Related]

  • 35. Acute leukemias in children with Down syndrome.
    Zwaan MC, Reinhardt D, Hitzler J, Vyas P.
    Pediatr Clin North Am; 2008 Feb 01; 55(1):53-70, x. PubMed ID: 18242315
    [Abstract] [Full Text] [Related]

  • 36. [Acute leukemias at the Complejo Hospitalario Metropolitano Dr. Arnulfo Arias M. from 1982 to 1990].
    Yunsán de Abood M, Arosemena R.
    Rev Med Panama; 1993 May 01; 18(2):151-4. PubMed ID: 8327746
    [Abstract] [Full Text] [Related]

  • 37. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A, Ohara A, Hasegawa D, Koh K, Saito T, Kiyokawa N, Kikuchi A, Takahashi H, Ikuta K, Hayashi Y, Hanada R, Tsuchida M, Tokyo Children's Cancer Study Group.
    Haematologica; 2008 Aug 01; 93(8):1155-60. PubMed ID: 18519521
    [Abstract] [Full Text] [Related]

  • 38. [Response rate of AML-XH-99 protocol in the treatment of 82 childhood acute myeloid leukemia].
    Li J, Gu LJ, Xue HL, Tang JY, Chen J, Zhao HJ, Chen J, Pan C, Wang YP, Ye H.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jun 01; 25(6):351-4. PubMed ID: 15308014
    [Abstract] [Full Text] [Related]

  • 39. Acute myeloid leukemia.
    Rubnitz JE, Gibson B, Smith FO.
    Pediatr Clin North Am; 2008 Feb 01; 55(1):21-51, ix. PubMed ID: 18242314
    [Abstract] [Full Text] [Related]

  • 40. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol.
    Bajel A, George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M.
    Pediatr Blood Cancer; 2008 Nov 01; 51(5):621-5. PubMed ID: 18688848
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.